These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9124393)

  • 1. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine.
    Wolzt M; Schmetterer L; Ferber W; Artner E; Mensik C; Eichler HG; Krejcy K
    Am J Physiol; 1997 Feb; 272(2 Pt 2):F178-82. PubMed ID: 9124393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitric oxide in the autoregulation of renal blood flow and glomerular filtration rate in aging spontaneously hypertensive rats.
    Kvam FI; Ofstad J; Iversen BM
    Kidney Blood Press Res; 2000; 23(6):376-84. PubMed ID: 11070417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
    Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
    Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
    Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
    Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
    Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM
    Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG; Thiemermann C
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of endothelial function of the renal vasculature in human subjects.
    Delles C; Jacobi J; Schlaich MP; John S; Schmieder RE
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.
    Spahr L; Martin PY; Giostra E; Niederberger M; Lang U; Capponi A; Hadengue A
    J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracarotid infusion of the nitric oxide synthase inhibitor, L-NMMA, modestly decreases cerebral blood flow in human subjects.
    Joshi S; Young WL; Duong DH; Ostapkovich ND; Aagaard BD; Hashimoto T; Pile-Spellman J
    Anesthesiology; 2000 Sep; 93(3):699-707. PubMed ID: 10969303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects.
    Jacobi J; Schneider MP; John S; Schmieder RE
    J Hypertens; 2002 Mar; 20(3):525-30. PubMed ID: 11875321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
    Bech JN; Nielsen CB; Pedersen EB
    Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid nongenomic effects of aldosterone on the renal vasculature in humans.
    Schmidt BM; Sammer U; Fleischmann I; Schlaich M; Delles C; Schmieder RE
    Hypertension; 2006 Apr; 47(4):650-5. PubMed ID: 16520409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response study of nitric oxide synthase inhibition in different vascular beds in man.
    Hjorth Lassen L; Klingenberg Iversen H; Olesen J
    Eur J Clin Pharmacol; 2003 Oct; 59(7):499-505. PubMed ID: 13680036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans.
    Bech JN; Nielsen CB; Ivarsen P; Jensen KT; Pedersen EB
    Am J Physiol; 1998 May; 274(5):F914-23. PubMed ID: 9612329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk.
    Schlaich MP; Oehmer S; Schneider MP; Delles C; Schmidt BM; Schmieder RE
    Atherosclerosis; 2007 May; 192(1):155-60. PubMed ID: 16765359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans.
    Sartori C; Lepori M; Busch T; Duplain H; Hildebrandt W; Bärtsch P; Nicod P; Falke KJ; Scherrer U
    Am J Respir Crit Care Med; 1999 Sep; 160(3):879-82. PubMed ID: 10471612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
    Kozlov AV; Sobhian B; Duvigneau JC; Costantino G; Gemeiner M; Nohl H; Redl H; Bahrami S
    J Lab Clin Med; 2002 Nov; 140(5):303-11. PubMed ID: 12434131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.